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ABSTRACT 
PURPOSE: With the increased survival rates in pediatric cancer, these patients are exhibiting 
new possible long-term side effects, such as delays in cognitive and social-emotional 
development. The purpose of this research study is to assess the cognitive and social-emotional 
developmental outcomes of pediatric cancer survivors who currently receive chemotherapy or 
have received chemotherapy in the past. 
DESIGN/METHODS: This pilot study used a quantitative survey to assess cognitive and 
social-emotional developmental outcomes of pediatric cancer survivors. The inclusion criteria 
for this study included parents of school aged children (ages 5-18) who received chemotherapy 
for at least six months, either currently or in the past. The data collected from the surveys was 
coded and analyzed through the IBM Statistical Package for Social Sciences (SPSS) for 
significance.  
RESULTS: Five participants were recruited either from a hematology and oncology clinic or a 
cancer survivorship group to fill out the survey. The results of this study were that there is most 
likely a difference in the developmental effects for patients who are currently receiving 
chemotherapy compared to those in remission who have previously received chemotherapy.  
CONCLUSIONS: These results indicate that that pediatric cancer survivors experience 
cognitive and social-emotional developmental effects, which may vary based on if the child is 
still receiving treatment or is in remission. As the number of pediatric cancer survivors 
increases, it is essential for healthcare professionals to understand and be aware of possible 
cognitive and social-emotional developmental changes related to chemotherapy. 
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Developmental Outcomes of Pediatric Cancer Survivors After Chemotherapy 
Due to recent advances in treatments, pediatric cancer patients have an increased 
survival rate associated with the implementation of various treatment measures (Li, 
Lopez, Chung, Ho, & Chiu, 2013). On average, there are over 375,000 pediatric cancer 
survivors in the United States, a number that has increased in the last forty years, which is 
commonly attributed to implementation of many different treatment methods, including 
chemotherapy (Ward et al., 2014). Implementation of chemotherapy to slow or stop 
growth of body cells, predominantly cancer cells, is a widely used form of treatment that 
has increased the survivorship of patients with childhood cancer when combined with an 
early diagnosis (Ward, DeSantis, Robbins, Kohler, & Jemal, 2014). The benefits from 
improved treatment measures is evident in the increasing survival rate, however, pediatric 
cancer survivors now face a higher risk of serious health conditions or developmental 
delays that have both chronic and late effects on the survivors (Miller et al., 2016). This 
research study will quantitatively assess the developmental outcomes of pediatric cancer 
survivors who currently receive chemotherapy or have received chemotherapy in the past. 
The developmental outcomes assessed in this study include cognitive and social-
emotional development, in order to investigate what deficits or delays may exist for these 
patients.  
Background 
The short-term impacts of chemotherapy during treatment often receive more 
attention in the research, while the long-term impacts of chemotherapy on pediatric 
cancer survivors is commonly underexplored within the research (Li et al., 2013). For 
pediatric cancer survivors, a cure comes at a cost, with increased risk and incidence of 
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cognitive or social-emotional developmental delays, months and even years after their 
chemotherapy treatment has ended (Li et al., 2013).  Previous research often evaluates 
cognitive and social-emotional developmental outcomes separately when looking at 
chemotherapy treatment effects on pediatric cancer patients or survivors. Through 
looking at the topics related to these developmental outcomes within the research, a 
broader understanding can be gained on what factors could possibly play a role in 
changing these developmental outcomes including the start, duration, and intensity of 
chemotherapy treatment. 
Cognitive Development  
 One-third of pediatric cancer survivors suffer from cognitive impairments, often 
due to chemotherapy treatment (Miller et al., 2016). Cognitive development deficits due 
to chemotherapy treatment can consist of different neurocognitive impairments, with 
diverse severity based on risk factors, such as a younger age at diagnosis (Buizer, de 
Sonneville, & Veerman, 2009). Younger children have less mature brain structures and a 
smaller amount of white matter, increasing their vulnerability to the neurotoxic effects of 
chemotherapy (Buizer et al., 2009). The most common long-term cognitive deficits found 
in pediatric cancer survivors receiving chemotherapy treatment, include alterations in 
attention and executive functioning (Buizer et al., 2009). Other cognitive developmental 
changes include altered or decreased processing speed, working memory, and visual 
spatial abilities (Lewis, Perry, & Murdoch, 2013). Other factors influenced by 
chemotherapy treatment that should be considered when looking at cognitive 
development, include both visual and hearing impairments (Ward et al., 2014). 
Additionally, pediatric cancer survivors who underwent chemotherapy treatment are 
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often found to have reduced language outcomes, vocabulary and grammar deficits, and 
reduction in naming abilities (Lewis et al., 2013).  
 For pediatric cancer survivors treated with chemotherapy, the long term cognitive 
deficits can also impact other aspects of their daily life. The various cognitive 
development deficits seen in survivors treated with chemotherapy often have a impact on 
intellectual and academic functioning (Raymond-Speden, Tripp, Lawarence, & 
Holdaway, 2000). Academic problems are evident from parent and teacher reports of 
survivors’ school performance, as well as, standardized test scores (Raymond-Speden et 
al., 2000). In addition, pediatric cancer survivors who were treated with chemotherapy 
have increased behavioral difficulties (Anderson, Godber, Smibert, Weiskop, & Ekert, 
2000). Long-term effects of chemotherapy on the cognitive state of pediatric cancer 
survivors may continue into adulthood, impacting quality of life, functional status, and 
behavioral adjustments (Moore, Hockenberry, & Krull, 2013). This shows the importance 
of early interventions to correct preventable developmental changes due to 
chemotherapy, and the importance of also analyzing social-emotional developmental in 
the provision of holistic care for pediatric cancer survivors.  
Social-Emotional Development 
 As the survival rates of pediatric cancer patients has increased, social-emotional 
development has become more of a priority, with a focus on the need for adequate health-
related quality of life for survivors. Health-related quality of life is a multidimensional 
concept that looks at “psychological functioning, physical state, social function, and 
capacity of performing activities of daily living” (Pemberger et al., 2005, p. 50). Similar 
to other developmental domains, social-emotional developmental deficits can have both 
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chronic and late effects, lasting years after the initial diagnosis and chemotherapy 
treatment (Pemberger et al., 2005). Pediatric cancer survivors treated with chemotherapy 
were commonly found to have lower health-related quality of life scores than healthy 
population controls of the same age and gender (Speechley, Barrera, Shaw, Morrison, & 
Manusell, 2006). For many survivors of childhood cancer, numerous factors influenced 
the differences in health-related quality of life scores, including the survivor’s age at 
diagnosis, cancer type, as well as, the type of treatment (Speechley et al., 2006). 
Additional issues that pediatric cancer survivors face that influence the overall health-
related quality of life, include health care utilization or availability, behavior problems, 
psychological issues, any second malignancies, late mortality, and socioeconomic status 
(Cantrell, 2011). Health-related quality of life is only one aspect of social-emotional 
development that highlights the numerous effects chemotherapy treatment can have on 
survivors.   
 Beyond health-related quality of life, pediatric cancer survivors treated with 
chemotherapy have been found to have negative emotional developmental outcomes, as 
well as, an increased risk of maladjustment when returning to normal activities (Cantrell, 
2011). When looking at the lasting impact of chemotherapy, survivors have been found to 
have an increased risk of depression and somatic distress due to psychologically stressful 
events during treatment and remission (Zebrack et al., 2002). In addition, pediatric cancer 
survivors have lower levels of self-esteem and increased levels of uncertainty and fear 
due to the possibility of second malignancies, when compared to their peers (Li et al., 
2013). Another major developmental change due to chemotherapy that survivors may 
face is social disruption or isolation (Li et al., 2013). Chemotherapy treatment decreases 
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the survivors’ immune response and increases their risk of infection, which leads to an 
alteration in their social patterns, such as frequent avoidance of crowded public places (Li 
et al., 2013). The shift in pediatric cancer survivors’ social interactions contributes to 
disrupted relationships and the feeling of being left out, which negatively impacts their 
social-emotional development (Li et al., 2013). In contrast to predominately negative 
social-emotional developmental outcomes, pediatric cancer survivors can have some 
positive developmental outcomes in response to their chemotherapy treatment. For 
example, many pediatric survivors developed a closer relationship with their family and 
became more mature, with a better ability to handle various problems after chemotherapy 
treatment (Yallop, McDowell, Koziol-McLain, & Reed, 2013).  
Significance of Study 
When dealing with pediatric cancer, health care professionals, parents and 
patients have to sometimes make difficult decisions between effective treatment 
measures, such as chemotherapy, and the possible long-term developmental effects. It is 
evident that the increased survival rate of pediatric cancer patients is attributed to medical 
advances in the field, including the improvement of treatment methods like 
chemotherapy. Developmental deficits and changes because of chemotherapy treatment is 
evident in all domains of development, including cognitive development and social-
emotional development. It is essential that health care professionals, such as nurses, are 
aware of these developmental changes that can occur in pediatric cancer survivors who 
were treated with chemotherapy.  This awareness allows for early identification of any 
potential problems. Currently, there is a lack of research that discusses the general 
developmental delays or deficits pediatric cancer survivors may face, especially a few 
DEVELOPMENTAL OUTCOMES  9 
 
years after remission. Also, there is a lack of research that compares the developmental 
outcomes of pediatric cancer survivors based on the age they received cancer treatment. 
Therefore, the implications of this study would be to begin to assess and identify 
commonalities in the cognitive and social-emotional developmental outcomes for 
pediatric cancer patients and survivors who have received chemotherapy.   
Purpose 
When looking at the purpose of this study, it is to evaluate the developmental 
outcomes of pediatric cancer patients who currently receive chemotherapy or have 
received chemotherapy in the past. It is intended that the findings from this study could 
contribute to the existing research, and prompt future investigation of the developmental 
outcomes of pediatric cancer survivors. This study also aims to identify if differences 
exist in cognitive and social-emotional developmental outcomes between pediatric cancer 
survivors, depending on the age they received chemotherapy treatment. The research 
questions addressed are (1) What are the long term cognitive and social-emotional 
development effects on pediatric cancer patients who received chemotherapy? (2) Is there 
a difference in the developmental outcomes for survivors, based on the age the receive 
cancer treatment? (3) Is there a difference in developmental effects for patients who are 
currently receiving chemotherapy compared to those in remission who previously 
received chemotherapy? It is hypothesized that every age group of pediatric cancer 
survivors will experience developmental delays or deficits in both cognitive and social-
emotional development. However, it is also hypothesized that there will be a difference in 
the developmental outcomes for survivors, based on what age they began receiving 
treatment. In addition, it is hypothesized that there will be a difference in the cognitive 
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and social-emotional development between patients who are currently still receiving 
treatment compared to those who have received treatment in the past. 
Method 
In this pilot study, the developmental outcomes were investigated for pediatric 
cancer patients who currently receive chemotherapy and survivors who have received 
chemotherapy in the past. Before beginning this study, the researcher obtained approval 
from the Georgia Southern University Institutional Review Board. Participants were 
recruited from the Pediatric Hematology and Oncology clinic at Memorial Health 
University Medical Center, as well as, from a cancer survivorship group. The participants 
of this study were parents of children that were school age (ages 5-18) and received 
chemotherapy for at least six months, either currently or in the past. The inclusion criteria 
for the parent or guardian to participate in the study was to be at least 18 years of age, 
have legal guardianship of the child, and know the child’s history. On select days 
questionnaires and informed consents were handed out in person to parents or guardians 
who had children that met the inclusion criteria. The questionnaire contained 
demographic information, information about the child’s cancer diagnosis and treatment, 
as well as, questions about the cognitive and social-emotional changes seen in the child 
(see Appendix B for questionnaire). Once the questionnaires were filled out, the parents 
or guardians returned surveys to the investigator. Questionnaires were then coded with no 
identifying information on them. The consents and questionnaires will be stored in 
separate locked boxes at Georgia Southern University School of Nursing, for three years 
of archival. Then after three years the surveys and informed consents will be destroyed. 
Data collected from the questionnaires was analyzed through IBM Statistical Package for 
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the Social Sciences (SPSS) software, to organize and interpret findings through 
descriptive statistics. 
Data Analysis and Results 
Five caregivers were recruited from an outpatient hematology and oncology clinic 
or a cancer survivorship group to participate in this study. Only one participant had a 
child who identified as “other race,” while the remaining children were reported as 
Caucasian (80%). Four of the five selected participants (80%) had daughters who were 
13-18 years of age and either currently receive or have previously received 
chemotherapy. In addition, the diagnosed female patients were 13-18 years old. The 
cancer diagnoses reported for the diagnosed females included “Acute Myeloid Leukemia 
(AML),” “Acute Lymphoblastic Leukemia (ALL),” and “Leukemia.” The only diagnosed 
male included in this study was in the 6-8 age group and had a diagnosis of “Stage IV 
high-risk neuroblastoma.” Two children were diagnosed between the ages of 3-5 years 
(40%), while the remaining children were diagnosed at 0-2 years (20%), 9-12 years 
(20%), and 16-18 years (20%). Also, two children were treated with chemotherapy alone, 
while the remaining children had additional forms of cancer treatment including bone 
marrow transplants, surgery, radiation, or immunotherapy. For the children included in 
this study, two have been in remission for more than 10 years, one has been in remission 
for 0-3 years, and two are still receiving treatment.   
During this study, the data was analyzed through IBM SPSS software to 
determine the results. When looking at the results, there were some similarities between 
all of the children regardless of age of diagnosis, length of treatment, or remission status. 
There was no indication of any speech problems for any of the children in this study, 
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since no issues were reported by parents on the questionnaire. Also, three children 
exhibited being “overtired without good reason” and “sleeping more than most kids 
during day or night” some of the time. In the short answer portion of the questionnaire, 
four out of five parents reported that their child was involved in at least two activities, 
sports, or hobbies. One parent did not fill in this question, so it is not known if that child 
participates in any activities. Some of the activities the children participate in include 
“volunteering, reading, art, cooking, walking, basketball, make-up, and working out.”  
When asked “compared to other children of similar age, my child’s behavior is 
different because of problems experienced during remission/treatment,” one parent 
strongly disagreed (20%), three parents disagreed (60%), and one parent neither agreed 
nor disagreed (20%).  Also, when looking at how the child gets along with siblings, other 
kids, and parents, the parents reported their children to be average (60%) or better than 
average (40%) when interacting with these groups. Specifically looking at the number of 
friends (not including siblings), parents reported their child having “2 or 3 friends” (60%) 
or “4 or more friends” (40%). Three of the children spend time with friends outside of 
school less than once a week, and two spend time with friends outside of school once or 
twice a week. Parents denied that their children break any rules at home, school or 
elsewhere. Also, the parents reported that none of the children receive special 
education/remediation services, have academic problems, or have behavioral problems at 
school. School performance was reported as average or above average, in reading and 
history for the all children. However, one child (20%) fell below average in math and two 
children (40%) were below average in science.  
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 From the children included in this study, two (40%) received treatment for 0-12 
months, and three (60%) received treatment for 1-3 years. The parents of the children 
treated for 1-3 years reported more issues than those treated for 0-12 months. Of the 
issues reported, 66% of those treated for 1-3 years reported that their children 
“impulsively act without thinking,” “are inattentive or easily distracted,” and “feel that 
he/she has to be perfect” sometimes or often. The remaining parents who had children 
receiving treatment for 0-12 months reported that these things were not true for their 
child. In addition, 66% of children treated for 1-3 years were reported as being 
“withdrawn, doesn’t given involved with others” along with “doesn’t get along with other 
kids” some of the time. However, there was little to no correlation between the length of 
treatment and the child’s academic performance or behavior for all participants.  
Similar to length of treatment, there were a few responses that were affected by 
the child’s age of diagnosis. One child was diagnosed between 0-2 years, two children 
were diagnosed between 3-5 years, one child was diagnosed between 9-12 years, and one 
child was diagnosed between 16-18 years. Some of the results seemed to be age 
dependent where they only effected either the older children (9-12 years and 16-18 years) 
or the younger children (0-2 years and 3-5 years). All of the parents of the older children 
(>9 years) reported that their child sometimes or often experiences difficulty with “sitting 
still, being restless or hyperactive,” while none of the parents of the younger children 
reported this. In contrast, 66% of younger children were reported by their parents to often 
“not get along with other kids,” where the parents of the older children reported not true.  
From parent reports, it was determined that 40% of the children were currently 
still receiving treatment/not in remission, 20% were in remission for 0-3 years, and 40% 
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were in remission for more than 10 years (see Appendix A: Table 1). When analyzing the 
results, the children were divided into those who were still receiving treatment and those 
in remission (0-3 years and more than 10 years). A cross-tabulation showed that all 
parents with children in remission reported that their child occasionally finds little he/she 
enjoys and are overtired without good reason. However, those still receiving treatment 
did not report these experiences. In addition, parents reported sometimes true for children 
in remission for 0-3 years and often true for children in remission for more than 10 years 
when asked if their child does not get along with other kids and would rather be alone 
than with others. Of the children in remission, parents reported that these children were 
sometimes “too shy or timid” and that 66% were sometimes or often “inattentive or easily 
distracted.” When asked if their child was “limited in schoolwork and activities” and 
“limited in the amount of time spent with friends,” parents with children currently in 
treatment reported agree or strongly agree to the statements, while parents with children 
in remission strongly disagreed or disagreed with the statements. The child in remission 
for 0-3 years was reported to sometimes “act too young for his/her age” and “feel 
worthless and inferior.” Also, the children in remission for 0-3 years and those still in 
treatment were reported to sometimes experience difficulty with “failing to finish things 
that he/she starts,” and sitting still, whereas those in remission for more than 10 years did 
not report difficulty with these things.  
Discussion and Implications of Findings 
The results of this study indicate that children who have been treated with 
chemotherapy, do not have significant academic or behavioral problems in school, and do 
not require special education/remediation services. The impact of chemotherapy on these 
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children is not as severe as previous research has indicated. However, it is still evident 
from the results that developmental problems continue to exist, but in a more minor way 
that could ideally be managed by the children and their families. Also, the results 
highlighted that children treated with chemotherapy have minimal behavior issues 
reported, which could suggest that these children experience other types of changes in 
their development after treatment.  
In addition, this study had an increased frequency of changes in social-emotional 
development than cognitive development after chemotherapy treatment. Social-emotional 
developmental outcomes include the child’s interaction with others, behavior changes 
such restlessness and irritability, as well as, the feeling of worthlessness and inability to 
finish tasks. The results of this study did include changes in both cognitive and social-
emotional development, which indicates that both can be affected by chemotherapy 
treatment. However, further research is needed to distinguish if one domain of 
development has more complications than the other. In order to further address the 
proposed research questions, the data was analyzed through cross-tabulations to evaluate 
if the length of treatment, age of diagnosis, or remission status could be factors that 
influenced the results.  
Length of Treatment  
When looking at the cross-tabulations, the length of treatment seemed to have an 
impact on some responses suggesting that increased chemotherapy exposure may have a 
greater impact on a child’s development. This is seen from the reports that children 
treated for 1-3 years tended to have more frequent issues than those treated from 0-12 
months. For example, children treated for 1-3 years were reported to sometimes or often 
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be inattentive or easily distracted, as well as, more likely to not get along with other kids. 
In this study, the child’s social-emotional development, such as interaction with others, 
impulsivity, and desire to be perfect, were more often impacted by the length of 
treatment. 
Age of Diagnosis 
The smaller sample size in this pilot study was primarily due to a lack of access to 
pediatric cancer patients or survivors that met the inclusion criteria of school age children 
(5-18 years) who have received chemotherapy for at least six months. This could have 
possibly influenced the lack of significance in the cross-tabulations between the age of 
diagnosis and developmental outcomes. There was some indication that the younger or 
older the child was at the age of diagnosis could possibly impact some developmental 
outcomes, but these trends were not consistent throughout the research. For this study, it 
can be concluded that the age of diagnosis did not impact the developmental outcomes 
for pediatric cancer survivors. While the age of diagnosis did not impact the 
developmental outcomes in this pilot study, a larger sample size could produce different 
trends and/or results. 
Remission Status 
 Cross-tabulations revealed trends between children who are currently still 
receiving chemotherapy and children who previously received treatment. There were 
differences in the changes in cognitive and social development for those currently 
receiving treatment versus those in remission. This indicates that the problems or 
complications pediatric cancer survivors or patients experience can start, disappear, or 
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change as the individual transitions from treatment to remission. Since remission is the 
goal for the majority of pediatric cancer patients, it is essential to know what variables to 
be aware of in order to ensure the best care is provided for this patient population to 
ensure the greatest quality of life. However, it is also important to assess whether other 
factors could be influencing these results, such as the weakened immune system and 
fatigue experienced by patients still receiving treatment. In addition, there are also 
specific differences in variables for survivors based on the number of years they have 
been in remission. There were not enough participants to represent each stage of 
remission in this study, however, a comparison was made among the children in early 
remission (0-3 years) and survivorship (>10 years). The comparison revealed that the 
early remission children exhibited immaturity and lower self-esteem, while those in the 
later stages of survivorship had difficulty with focusing and excessive hyperactivity.  
Even more specifically, out of the five children in this study four were 13-18 
years old females, diagnosed with a form of leukemia. By eliminating other possible 
factors that could influence questionnaire responses such as type of cancer, age, and 
gender, the female group provided insight on how developmental outcomes could be 
different for those in treatment compared to those in remission. Children in early 
remission (0-3 years) were reported to sometimes have difficulty getting along with other 
kids or being too shy, while children in later remission (more than 10 years) reported 
these to occur more often (see Appendix A: Table 2). For children still receiving 
treatment they were reported to have difficulty finishing things he/she starts and being 
confused or in a fog (see Appendix A: Table 2). These differences could be explained by 
the fact that the impacts on a child’s development from chemotherapy may be drastically 
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different while the child is actively receiving the drug compared to having previously 
been given the drug and instead dealing with the residual effects of chemotherapy. 
Through these results, it can be concluded that there is most likely a difference in the 
developmental outcomes between patients who are currently receiving chemotherapy and 
those in remission who have previously received chemotherapy.  
Recommendations 
This research study revealed long term effects on cognitive and social-emotional 
developmental that can differ based on if the patient is currently receiving chemotherapy 
treatment or is in remission. The results from this study can be implemented to enhance 
existing research or serve as the foundation for new research on the developmental 
outcomes of pediatric cancer survivors. For future studies, recommendations include 
increasing the sample size to promote a comprehensive assessment of the cognitive and 
social-emotional developmental changes that may occur in pedantic cancer survivors. In 
addition, it could be helpful to have parents of healthy children also complete the 
questionnaire to provide a group to compare the pediatric cancer survivors with. By 
surveying healthy children, future researchers will be able to possibly distinguish if 
developmental changes are normal at certain ages or are directly related to chemotherapy 
treatment. 
Conclusion 
From the results of this pilot study, it can be inferred that pediatric cancer 
survivors experience cognitive and social-emotional developmental changes, which may 
vary based on if the child is currently receiving chemotherapy or has previously received 
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chemotherapy, and how long they have been treated with chemotherapy. As the number 
of pediatric cancer survivors increases, it is essential for healthcare professionals to 
understand and be aware of possible cognitive and social-emotional developmental 
changes related to chemotherapy. Through additional research, the knowledge base of 
health care providers can expand to ultimately improve the effort towards early 
identification and education about developmental changes related to chemotherapy. Due 
to the increased number of pediatric cancer survivors, it is essential to work towards 
better developmental outcomes for these children to improve their overall quality of life.  
  
DEVELOPMENTAL OUTCOMES  20 
 
References 
Anderson, V. A., Godber, T., Smibert, E., Weiskop, S., & Ekert, H. (2000). Cognitive 
and academic outcome following cranial irradiation and chemotherapy in 
children: A longitudinal study. British Journal of Cancer, 82 (2), 255-262. 
doi:10.1054/bjoc.1999.0912 
Buizer, A. I., de Sonneville, L. M., & Veerman, A. J. (2009). Effects of chemotherapy on 
neurocognitive function in children with acute lymphoblastic leukemia: A critical 
review of the literature. Pediatric blood & cancer, 52 (4), 447-454. 
doi:10.1002/pbc.21869  
Cantrell, M. A. (2011). A narrative review summarizing the state of the evidence on the 
health-related quality of life among childhood cancer survivors. Journal of 
Pediatric Oncology Nursing, 28 (2), 75-82. doi:10.1177/1043454210377901  
Lewis, F. M., Perry, M. L., & Murdoch, B. E. (2013). Longitudinal language outcomes 
following intrathecal chemotherapy for acute lymphoblastic leukaemia. 
International Journal of Speech-Language Pathology, 15 (2), 156-164. 
doi:10.3109/17549507.2012.684888 
Li, H. W., Lopez, V., Chung, O. J., Ho, K. Y., & Chiu, S. Y. (2013). The impact of 
cancer on the physical, psychological and social well-being of childhood cancer 
survivors. European Journal of Oncology Nursing, 17 (2), 214-219. 
http://dx.doi.org/10.1016/j.ejon.2012.07.010 
DEVELOPMENTAL OUTCOMES  21 
 
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. 
H.,…Jemal, A. (2016). Cancer treatment and survivorship statistics, 2016. CA: A 
Cancer Journal for Clinicians, 66 (4), 271-289. doi:10.3322/caac.21349  
Moore, I. M. K., Hockenberry, M. J., & Krull, K. R. (2013). Cancer-related cognitive 
changes in children, adolescents and adult survivors of childhood cancers. 
Seminars in Oncology Nursing, 29 (4), 248-259. 
http://dx.doi.org/10.1016/jsoncn.2013.08.005  
Pemberger, S., Jagsch, R., Frey, E., Felder-Puig, R., Gadner, H., Kryspin-Exner, I., & 
Topf, R. (2005). Quality of life in long-term childhood cancer survivors and the 
relation of late effects and subjective well-being. Supportive Care in Cancer, 13 
(1), 49-56. doi:10.1007/s00520-004-0724-0  
Raymond-Speden, E., Tripp, G., Lawrence, B., & Holdaway, D. (2000). Intellectual, 
neuropsychological, and academic functioning in long-term survivors of 
leukemia. Journal of Pediatric Psychology, 25 (2), 59-68. 
doi:10.1093/jpepsy/25.2.59  
Speechley, K. N., Barrera, M., Shaw, A. K., Morrison, H. I., & Maunsell, E. (2006). 
Health-related quality of life among child and adolescent survivors of childhood 
cancer. Journal of Clinical Oncology, 24 (16), 2536-2543. 
doi:10.1200/JCO.2005.03.9628 
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014). Childhood and 
adolescent cancer statistics, 2014. CA: A Cancer Journal for Clinicians, 64 (2), 
83-103. doi:10.3322/caac.21219  
DEVELOPMENTAL OUTCOMES  22 
 
Yallop, K., McDowell, H., Koziol-McLain, J., & Reed, P. W. (2013). Self-reported 
psychosocial wellbeing of adolescent childhood cancer survivors. European 
Journal of Oncology Nursing, 17 (6), 711-719. doi:10.1016/j.ejon.2013.06.007 
Zebrack, B. J., Zeltzer, L. K., Whitton, J., Mertens, A. C., Odom, L., Berkow, R., & 
Robison, L. L. (2002). Psychological outcomes in long-term survivors of 
childhood leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma: A report 
from the childhood cancer survivor study. Pediatrics, 110 (1), 42-52. Retrieved 
from http://pediatrics.aappublications.org/content/110/1/42.short  
 
 
 
 
 
 
 
 
  
DEVELOPMENTAL OUTCOMES  23 
 
Appendix A 
Table 1 
 
Child Age 
6-8 13-15 16-18 
Years in 
Remission 
N/A; my child is still 
receiving treatment 
1 0 1 
0-3 years 0 1 0 
More than 10 years 0 0 2 
    
 
Table 2 
 
 
Years in Remission 
N/A; my child 
is still 
receiving 
treatment 0-3 years 
More than 10 
years 
Doesn’t get 
along with other 
kids 
Not True 2 0 0 
Sometimes True 0 1 0 
Very True or Often True 0 0 2 
Too shy or timid Not True 2 0 0 
Sometimes True 0 1 2 
Very True or Often True 0 0 0 
Fails to finish 
things he/she 
starts 
Did Not Answer 
Not True 
0 
1 
0 
0 
1 
1 
Sometimes True 1 1 0 
Very True or Often True 0 0 0 
Confused or 
seems to be in a 
fog 
Not True 1 0 0 
Sometimes True 1 1 1 
Very True or Often True 0 0 1 
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Appendix B  
Developmental Outcomes of Pediatric Cancer Survivors After Chemotherapy-Survey 
 
What is your gender? 
 Male 
 Female 
 
What is your age? 
 18-29 
 30-39 
 40-49 
 50-59 
 60-69 
 70+ 
 
What is the highest level of school you have completed or the highest degree you 
have received?  
 Less than high school degree 
 High school graduate (high school diploma or equivalent including GED) 
 Some college but no degree 
 Associate degree in college (2-year) 
 Bachelor's degree in college (4-year) 
 Master's degree 
 Doctoral degree 
 Professional degree (JD, MD) 
 
What is your child's gender? 
 Male 
 Female 
 
Choose one or more races that you consider your child to be: 
 White 
 Black or African American 
 American Indian or Alaska Native 
 Asian 
 Native Hawaiian or Pacific Islander 
 Other ____________________ 
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What is the age of your child currently? 
 0-2 
 3-5 
 6-8 
 9-12 
 13-15 
 16-18 
 Other_______________ 
 
What was your child's age at time of their diagnosis? 
 0-2 
 3-5 
 6-8 
 9-12 
 13-15 
 16-18 
 Other_______________ 
 
What kind(s) of cancer has your child been diagnosed with, either currently or in 
the past? (Please be as descriptive as possible). 
________________________________________________________________________
________________________________________________________________________ 
 
How long has your child received treatment for their cancer, including any current 
or previous treatment? 
 0-6 months 
 6 months-1 year 
 1-3 years 
 4-5 years 
 5-10 years 
 10 or more years 
 
What form(s) of treatment has your child received, either currently or in the past? 
(Select all that apply).  
 Chemotherapy 
 Radiation 
 Bone Marrow/Stem Cell Treatments 
 Surgery 
 Transplant 
 Other______________ 
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If applicable, how many years has your child been in remission?  
 Not applicable: my child is still receiving treatment  
 0-3 years 
 3-5 years 
 5-8 years 
 8-10 years 
 More than 10 years 
 
How many sports, hobbies, activities, jobs, or games does your child participate in? 
 None 
 1-3 
 4-6 
 7-9 
 More than 10 
 
 
Please list a few of the sports, hobbies, activities, jobs or games your child 
participates in the blanks, and answer the following questions. (It is not required to 
fill in all of the blanks)  
 
 
 
 
Less 
than 
average 
Average 
More 
than 
Average 
Don't 
Know 
 
Less 
than 
average 
Average 
More 
than 
Average 
Don't 
Know 
1._________                  
2._________                  
3._________                  
4._________                  
5._________                  
 
Please answer the following questions about your child's academic performance.  
 Does not attend school because___________________________________________ 
 
Compared to others of the same 
age, about how much time does 
he/she spend in each? 
Compared to others of the same 
age, how well does he/she do 
each one? 
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Check a box for each subject based on how your child is currently performing.  
 Failing 
Below 
Average 
Average 
Above 
Average 
Reading, 
English, or 
Language Arts 
        
History or 
Social Studies 
        
Math         
Science         
Foreign 
Languages 
        
Electives (gym, 
computer 
courses, etc.) 
        
 
 
Does your child receive special education or remedial services or attend a special 
class or special school? Please explain in general terms, using no identifying 
information.  
 No 
 Yes- kind of services, class, or school______________________________________ 
_____________________________________________________________________
_____________________________________________________________________ 
 
Has your child repeated any grades? 
 No 
 Yes- grades repeated and reasons__________________________________________ 
_____________________________________________________________________ 
 
Has your child had any academic problems in school? 
 No 
 Yes-Please describe____________________________________________________ 
 
Has your child had any behavioral problems in school?  
 No 
 Yes-Please describe____________________________________________________ 
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About how many close friends does your child have? (Do not include brothers & 
sisters) 
 None 
 1 
 2 or 3 
 4 or more 
 
About how many times a week does your child do things with any friends outside of 
regular school hours? (Do not include brothers & sisters) 
 Less than 1 
 1 or 2 
 3 or more  
 
Compared to others of his/her age, how well does your child:  
 Worse Average Better Not applicable 
Get along with 
his/her brothers 
& sisters? 
        
Get along with 
other kids? 
        
Behave with 
his/her 
parents? 
        
Play and work 
alone? 
        
 
 
Below is a list of items that describe children. For each item, choose the answer that 
currently best describes your child. Please answer all of the items as well as you can, 
even if some do not seem to apply to your child.  
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Not True (as far 
as you know) 
Somewhat or 
Sometimes True 
Very True or 
Often True 
Acts too young for his/her age       
Fails to finish things he/she 
starts 
      
There is very little he/she enjoys       
Can't concentrate, can't pay 
attention for long 
      
Can't sit still, restless, or 
hyperactive 
      
Confused or seems to be in a fog       
Daydreams or gets lost in his/her 
thoughts 
      
Feels he/she has to be perfect       
Feels worthless or inferior       
Impulsive acts without thinking       
Overtired without good reason       
Poor school work       
Refuses to talk       
Sleeps less than most kids       
Sleeps more than most kids 
during day or night 
      
Inattentive or easily distracted       
Speech problem       
Argues a lot       
Clings to adults or too dependent       
Complains of loneliness       
Disobedient at home       
Disobedient at school       
Doesn't get along with other kids       
Breaks rules at home, school, or 
elsewhere 
      
Would rather be alone than with 
others 
      
Too shy or timid       
Withdrawn, doesn't get involved 
with others 
      
Unhappy, sad, or depressed       
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For each of the following statements related to your child select: strongly disagree, 
disagree, neither agree nor disagree, agree, or strongly agree.  
 
Strongly 
Disagree 
Disagree 
Neither agree 
nor disagree 
Agree 
Strongly 
Agree 
My child has 
been limited in 
schoolwork and 
activities he/she 
could do, due to 
problems 
experienced 
during remission. 
          
My child has 
been limited in 
the amount of 
time spent with 
friends due to 
problems 
experienced 
during remission. 
          
My child feels 
satisfied about 
their school 
ability, 
friendships, and 
life overall. 
          
Compared to 
other children of 
similar age, my 
child behavior is 
different because 
of problems 
experienced 
during remission. 
          
 
Please elaborate or describe any developmental changes (if any) you have noticed 
since your child began their cancer treatment.  Do not use any identifying 
information in your response.  
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
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What concerns you most about your child? Do not use any identifying information 
in your response.  
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
Please describe the best things about your child. Do not use any identifying 
information in your response.  
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
 
 
